[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354415-105":59,"doc-detail-354415-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluating-immunoreactivity-of-hybridoma-derived-antibody-mixtures-generated-against-au-565-cell-line-for-diagnosis-and-immunotherapy-of-breast-cancer","Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer","","A study generated antibodies against whole-cell lysate of the AU-565 breast cancer cell line using hybridoma technology, then assessed immunogenic properties and preliminary immunoassay-oriented reactivity. Complete Freund’s Adjuvant (CFA) and Polyoxidonium (PO) were compared for immune response enhancement, including cytokine profiling. AU-565 lysates were tested by nitric oxide production in J774 macrophages and antibody titers in Balb/c mice, with ELISA quantifying IL-6, IL-12, GM-CSF, and TNF-α.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluating-immunoreactivity-of-hybridoma-derived-antibody-mixtures-generated-against-au-565-cell-line-for-diagnosis-and-immunotherapy-of-breast-cancer/354415/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluating-immunoreactivity-of-hybridoma-derived-antibody-mixtures-generated-against-au-565-cell-line-for-diagnosis-and-immunotherapy-of-breast-cancer/354415.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What antibodies were generated and against which antigen source?","Question",{"text":112,"@type":113},"Antibodies were generated against the whole-cell lysate of the AU-565 breast cancer cell line using hybridoma technology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were immune and antibody responses evaluated?",{"text":117,"@type":113},"Immunostimulatory activity was evaluated in vitro via nitric oxide production in J774 macrophages and in vivo by antibody titers in Balb/c mice.",{"name":119,"@type":110,"acceptedAnswer":120},"Which adjuvant showed stronger effects in the AU-565 models?",{"text":121,"@type":113},"The AU-565 antigen plus CFA formulation produced significantly higher NO in macrophages and generated the strongest antibody titers versus the PBS control, with increased IL-12, GM-CSF, and TNF-α.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354415,1791162739,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Ihlamur et al. BMC Cancer (2026) 26:811 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16143-7](https://doi.org/10.1186/s12885-026-16143-7)  \nRESEARCH Open Access  \nEvaluating immunoreactivity of hybridomaderived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer  \nMurat Ihlamur 1,2*, Atıfcan Deṁirċioğlu1, Aslı Pınar Zorba3, Emrah Şefik Abamor1, Melahat Bağırova4,5 and Adil Allahverḋiyev4,5  \nAbstract  \nBackground This study aimed to generate antibodies against the whole-cell lysate of the AU-565 breast cancer cell line using hybridoma technology and to assess their immunogenic properties and preliminary immunoassay-oriented reactivity. Two adjuvants, Complete Freund’s Adjuvant (CFA) and Polyoxidonium (PO), were compared for their ability to enhance immune responses. Cytokine profiling was also performed to evaluate the immunomodulatory effects of antigen–adjuvant formulations.  \nMethods AU-565 cell lysates were prepared by sonication and combined with CFA or PO. Immunostimulatory activity was evaluated in vitro by nitric oxide (NO) production in J774 macrophages and in vivo by antibody titers in Balb/c mice. Hybridoma cells were generated from splenocytes of immunized mice. Since single-cell cloning was not performed, antibodies were collected from pooled hybridoma cultures, representing a mixture of monoclonal antibodies recognizing multiple epitopes. Cytokine levels (IL-6, IL-12, GM-CSF, and TNF-α) were quantified by ELISA to characterize the inflammatory response pattern induced by the antigen–adjuvant formulations.  \nResults The AU-565 antigen + CFA formulation significantly increased NO production compared with untreated control macrophages and generated the strongest antibody titers compared with the PBS control group. Cytokine profiling showed that the AU-565 antigen + CFA formulation significantly increased IL-12, GM-CSF, and TNF-α secretion compared with untreated control macrophages, indicating a pronounced pro-inflammatory response pattern in the macrophage model, while a moderate IL-6 increase relative to untreated control macrophages suggested partial support for humoral-associated signaling. The hybridoma-derived antibody mixture displayed stronger  \nELISA reactivity toward AU-565 and MCF-7 lysates than the commercial antibody, indicating broader relative lysate recognition under the assay conditions used.  \nConclusion The hybridoma-derived antibody mixture showed strong immunogenicity, cytokine-associated immune stimulation, and preliminary potential for breast cancer-oriented immunoassay development; however, additional  \n*Correspondence: Murat Ihlamur [mihlamur@biruni.edu.tr](mihlamur@biruni.edu.tr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nIhlamur et al. BMC Cancer (2026) 26:811 Page 2 of 15  \nvalidation of specificity and analytical performance is required before diagnostic utility can be concluded. The AU-565 antigen–CFA combination not only enhanced antibody product","cbCaimOagJIQAlnW","https://ap.wps.com/l/cbCaimOagJIQAlnW","pdf",2325063,15,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What antibodies were generated and against which antigen source?\",\"answer\":\"Antibodies were generated against the whole-cell lysate of the AU-565 breast cancer cell line using hybridoma technology.\"},{\"question\":\"How were immune and antibody responses evaluated?\",\"answer\":\"Immunostimulatory activity was evaluated in vitro via nitric oxide production in J774 macrophages and in vivo by antibody titers in Balb/c mice.\"},{\"question\":\"Which adjuvant showed stronger effects in the AU-565 models?\",\"answer\":\"The AU-565 antigen plus CFA formulation produced significantly higher NO in macrophages and generated the strongest antibody titers versus the PBS control, with increased IL-12, GM-CSF, and TNF-α.\"}]","Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer | PDF",1790110513,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3cd0c40ce63231cabdc197db9825eda.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccdeef039a5a0de403882d6284f5b458.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7c3676dd2b8e958c141729653bde8ab.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae14b957d99f2dba6481a84ade1d4410.webp",980,1306]